NeuroBo Pharmaceuticals
obesity nash upcoming study overviews a | NeuroBo Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
20 of 30
Related slides by other companies
Theranos
Investor Conference
August 2016
lymphocyte subset method comparison study overview | Theranos
Theranos
Investor Conference
August 2016
clinical chemistry method comparison study overview | Theranos
BioAtla
Investor Presentation
May 2023
phase study design with | BioAtla
BioAtla
Investor Presentation
August 2023
phase study design with in refractory patients | BioAtla
Other recent decks by NeuroBo Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
March 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io